869 related articles for article (PubMed ID: 30446471)
1. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
McVary KT; Rogers T; Mahon J; Gupta NK
J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
[TBL] [Abstract][Full Text] [Related]
2. Three-Year Treatment Outcomes of Water Vapor Thermal Therapy Compared to Doxazosin, Finasteride and Combination Drug Therapy in Men with Benign Prostatic Hyperplasia: Cohort Data from the MTOPS Trial.
Gupta N; Rogers T; Holland B; Helo S; Dynda D; McVary KT
J Urol; 2018 Aug; 200(2):405-413. PubMed ID: 29499208
[TBL] [Abstract][Full Text] [Related]
3. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
[TBL] [Abstract][Full Text] [Related]
4. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.
McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
J Sex Med; 2016 Jun; 13(6):924-33. PubMed ID: 27129767
[TBL] [Abstract][Full Text] [Related]
5. Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia.
Roehrborn CG; Rukstalis DB
Eur Urol Focus; 2022 Jan; 8(1):217-227. PubMed ID: 33436276
[TBL] [Abstract][Full Text] [Related]
6. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia.
McVary KT; El-Arabi A; Roehrborn C
Sex Med; 2021 Dec; 9(6):100454. PubMed ID: 34731779
[TBL] [Abstract][Full Text] [Related]
7. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
[TBL] [Abstract][Full Text] [Related]
8. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
[TBL] [Abstract][Full Text] [Related]
9. Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial.
Kaplan SA; Lee JY; Meehan AG; Kusek JW
J Urol; 2016 Jun; 195(6):1825-9. PubMed ID: 26678956
[TBL] [Abstract][Full Text] [Related]
10. Finasteride for benign prostatic hyperplasia.
Tacklind J; Fink HA; Macdonald R; Rutks I; Wilt TJ
Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD006015. PubMed ID: 20927745
[TBL] [Abstract][Full Text] [Related]
11. Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study.
Macoska JA; Uchtmann KS; Leverson GE; McVary KT; Ricke WA
J Urol; 2019 Dec; 202(6):1240-1247. PubMed ID: 31188728
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.
Logan YT; Belgeri MT
Am J Geriatr Pharmacother; 2005 Jun; 3(2):103-14. PubMed ID: 16129387
[TBL] [Abstract][Full Text] [Related]
13. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
14. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
Gupta NK; Gange SN; McVary KT
Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
[TBL] [Abstract][Full Text] [Related]
15. [Negative effects on sexual function of medications for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; de La Taille A; Giuliano F; Desgrandchamps F; Doridot G
Prog Urol; 2015 Mar; 25(3):115-27. PubMed ID: 25605342
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia With Severe Lower Urinary Tract Dysfunction With Combination of Dutasteride and Solifenacin.
Kosilov K; Kuzina I; Kuznetsov V; Gainullina Y; Kosilova L; Karashchuk E; Prokofyeva A; Loparev S
J Sex Med; 2018 Nov; 15(11):1579-1590. PubMed ID: 30415813
[TBL] [Abstract][Full Text] [Related]
17. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
Gacci M; Ficarra V; Sebastianelli A; Corona G; Serni S; Shariat SF; Maggi M; Zattoni F; Carini M; Novara G
J Sex Med; 2014 Jun; 11(6):1554-66. PubMed ID: 24708055
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study.
Rosen RC; Roehrborn CG; Manyak MJ; Palacios-Moreno JM; Wilson TH; Lulic Z; Giuliano F
Int J Clin Pract; 2019 Sep; 73(9):1-9. PubMed ID: 30317693
[TBL] [Abstract][Full Text] [Related]
19. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
20. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
McVary KT; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Pliskin M; Beahrs JR; Prall D; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Tadros NN; Gange SN; Roehrborn CG
J Urol; 2021 Sep; 206(3):715-724. PubMed ID: 33872051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
